![David Andrew Arlwydd Owen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Andrew Arlwydd Owen
Directeur/Membre du Conseil chez
Oxford Gene Technology IP Ltd.
Profil
David Andrew Arlwydd Owen is the founder of MVM Ltd. He currently holds director positions at Oxford Gene Technology IP Ltd. and Oxford Gene Technology (Operations) Ltd. He previously held director positions at Ardana Plc, Cobra Therapeutics Ltd., RiboTargets Ltd., Prolifix Ltd., Imaxio SA, and Elara Pharmaceuticals GmbH.
He also served as Group Director-Compound & Technology Acquisitions at SmithKline & French SpA and as Non-Executive Chairman at AERES Biomedical Ltd.
Postes actifs de David Andrew Arlwydd Owen
| Sociétés | Poste | Début |
|---|---|---|
Oxford Gene Technology IP Ltd.
 Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Directeur/Membre du Conseil | - |
Oxford Gene Technology (Operations) Ltd.
 Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops, manufactures and markets molecular genetics | Directeur/Membre du Conseil | 07/09/2005 |
Anciens postes connus de David Andrew Arlwydd Owen
| Sociétés | Poste | Fin |
|---|---|---|
Cobra Therapeutics Ltd.
 Cobra Therapeutics Ltd. Medical SpecialtiesHealth Technology Manufactures cancer therapeutics on contract basis | Directeur/Membre du Conseil | 12/11/2007 |
RiboTargets Ltd.
 RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company | Directeur/Membre du Conseil | 12/11/2007 |
MVM Ltd.
 MVM Ltd. Gas DistributorsUtilities Distributes natural gas and electricity | Fondateur | - |
Elara Pharmaceuticals GmbH
 Elara Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Focuses on the development of novel treatments for malignant diseases | Directeur/Membre du Conseil | - |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Ardana Plc
 Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Health Technology |
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Finance |
Cobra Therapeutics Ltd.
Cobra Therapeutics Ltd. Medical SpecialtiesHealth Technology Manufactures cancer therapeutics on contract basis | Health Technology |
RiboTargets Ltd.
RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company | Health Technology |
SmithKline & French SpA
 SmithKline & French SpA Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Prolifix Ltd.
 Prolifix Ltd. Miscellaneous Commercial ServicesCommercial Services Operates in the pharmaceutical research and development sector | Commercial Services |
AERES Biomedical Ltd.
 AERES Biomedical Ltd. Drugstore ChainsRetail Trade Develops therapeutic antibodies | Retail Trade |
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Develops biopharmaceutical products | Health Technology |
Elara Pharmaceuticals GmbH
Elara Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Focuses on the development of novel treatments for malignant diseases | Health Technology |
MVM Ltd.
MVM Ltd. Gas DistributorsUtilities Distributes natural gas and electricity | Utilities |
Oxford Gene Technology IP Ltd.
Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Oxford Gene Technology (Operations) Ltd.
Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops, manufactures and markets molecular genetics | Health Technology |
